ClinicalTrials.gg
Sign In
CompletedNCT05635890Updated Dec 2, 2022

Effect of Vestibular Rehabilitation on Trunk Kinetic and Kinematic Parameters in Patients With Multiple Sclerosis

An interventional study of Cawthorne Cooksey exercise protocol and conventional vestibular rehabilitation in Vestibular Rehabilitation in MS, sponsored by October 6 University. Completed at 1 site in Egypt. Open to participants aged 35 Years to 55 Years. Per ClinicalTrials.gov, last updated 2022-12-02.

Sponsored by October 6 University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 6 months after the study started (first participant enrolled May 2022, registered Nov 2022).
Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Randomized
Ages
35 Years to 55 Years
Sex
All
01

Study summary

The Cawthorne Cooksey exercises and conventional program of physical therapy were administered.

Read the detailed description
  • The Cawthorne Cooksey exercises and conventional program of physical therapy were administered.
02

Conditions studied

  • Vestibular Rehabilitation in MS

Browse trials for

Keywords

  • Trunk kinetic and kinematic parameters, Vestibular rehabilitation, Multiple Sclerosis.
03

In context

Multiple Sclerosis

3,524 studies on the registry are indexed under Multiple Sclerosis; 668 are open to participants now.

This study's enrollment of 30 is below the median of 50 across 2,386 interventional studies indexed under Multiple Sclerosis.

Browse Multiple Sclerosis studies →

Lead sponsor

October 6 University is the lead sponsor of 142 studies on the registry; 28 are open to participants now.

Browse October 6 University studies →

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
35 Years to 55 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Aged 35-55 years.
  • Ambulatory without assistance.
  • Diagnosed with relapsing-remitting MS by a neurologist, with approximately five relapse attacks in the hemiparesis type with a muscular tone of 1 or 1+ depending on the MAS, or modified Ashworth scale.
  • All individuals were evaluated by a neurosurgeon to confirm central vertigo using test of Dix Hallpike.
  • Degree of MS-related disability based on the enlarged disability status scale, ranging from 2-2.5.

Exclusion criteria

Exclusion Criteria:

  • People with musculoskeletal deformities.
  • People with inner ear abnormalities.
  • People with psychiatric disturbances or seizures.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Investigator)
Enrollment
30 participants (actual)

Study arms

  • Experimental
    Group I

    received conventional vestibular rehabilitation along with the Cawthorne Cooksey exercise protocol

    Other: Cawthorne Cooksey exercise protocol · Other: conventional vestibular rehabilitation

  • Active comparator
    Group II

    received conventional vestibular rehabilitation only

    Other: conventional vestibular rehabilitation

Interventions

  • OtherCawthorne Cooksey exercise protocol

    Cawthorne Cooksey exercise protocol

  • Otherconventional vestibular rehabilitation

    conventional vestibular rehabilitation

06

What researchers measure

Primary outcomes

  1. Isokinetic dynamometer (average power)

    Assess trunk kinetic and kinematic parameters.

    Time frame: 4 weeks

  2. Isokinetic dynamometer (acceleration time)

    Assess trunk kinetic and kinematic parameters.

    Time frame: 4 weeks

  3. Isokinetic dynamometer (deceleration time)

    Assess trunk kinetic and kinematic parameters.

    Time frame: 4 weeks

07

Study locations

1 site
  • October 6 University
    El-Sheikh Zayed City, Giza Governorate 1133, Egypt
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from May 2022 to primary completion in Aug 2022, 3 months.

Of 868 non-industry interventional studies with no phase under Multiple Sclerosis, half reached primary completion within 22 months of starting (the median), counting those still running; a quarter within 9 and three quarters within 43. This study's 3 months is below that.

Counting every sponsor, half of 889 studies reached it within 21 months; a quarter within 9 and three quarters within 43.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 13, 2022
First posted
Dec 2, 2022
StartActual
May 6, 2022
Primary completionActual
Aug 10, 2022
CompletionActual
Sep 20, 2022
Last update
Dec 2, 2022
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Dec 2, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05635890
Lead sponsor
October 6 University
Responsible party
Ahmed Magdy Alshimy (Lecturer of Physical Therapy at department of neurology, October 6 University) — Principal investigator
First posted
Dec 2, 2022
Start date
May 6, 2022
Primary completion
Aug 10, 2022
Completion
Sep 20, 2022
Last update
Dec 2, 2022

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies in this condition

Multiple Sclerosis →

Other studies from this sponsor

October 6 University →

Start the discussion